Insights into AT1 Receptor Activation through AngII Binding Studies

Journal of Chemical Information and Modeling

Volumn 53, Issue 11, 2013, Pages 2798-2811

  Matsoukas, Minos Timotheos ^a   Potamitis, Constantinos ^b   Plotas, Panayiotis ^c   Androutsou, Maria Eleni ^c   Agelis, George ^c   Matsoukas, John ^c   Zoumpoulakis, Panagiotis ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSTITUTE OF BIOLOGY   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL ENGINEERING; CHEMISTRY;

ACTIVATION MECHANISMS; ANGIOTENSIN II; BINDING PROFILES; BINDING STUDIES; DYNAMIC CHANGES; FLEXIBLE DOCKING; G PROTEIN COUPLED RECEPTORS; STRUCTURAL REARRANGEMENT;

CHEMICAL ACTIVATION;

ACETIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; CHEMOKINE RECEPTOR CXCR4; CXCR4 PROTEIN, HUMAN; DIMETHYL SULFOXIDE; LIGAND; TRIFLUOROACETIC ACID;

ARTICLE; BINDING SITE; CHEMISTRY; HUMAN; MOLECULAR DOCKING; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN BINDING; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; STRUCTURAL HOMOLOGY; THERMODYNAMICS;

ACETIC ACID; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BINDING SITES; DIMETHYL SULFOXIDE; HUMANS; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR DOCKING SIMULATION; MOLECULAR DYNAMICS SIMULATION; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, CXCR4; STRUCTURAL HOMOLOGY, PROTEIN; THERMODYNAMICS; TRIFLUOROACETIC ACID;

EID: 84888633910     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci4003014     Document Type: Article

References (65)

1. Messerli, F.; Weber, M. A.; Brunner, H. R. Angiotensin II receptor inhibition: A new therapeutic principle arch. Intern. Med. 1996, 156, 1957-1965
2. Goodfriend, T. L.; Elliott, M. E.; Catt, K. J. angiotensin receptors and their antagonists N. Engl. J. Med. 1996, 334, 1649-1655
3. 2 adrenergic receptor-Gs protein complex Nature 2011, 477, 549-555
4. 2A adenosine receptor Science 2011, 332, 322-327
5. White, J. F.; Noinaj, N.; Shibata, Y.; Love, J.; Kloss, B.; Xu, F.; Gvozdenovic-Jeremic, J.; Shah, P.; Shiloach, J.; Tate, C. G.; Grisshammer, R. Structure of the agonist-bound neurotensin receptor Nature 2012, 490, 508-513
6. Hunyady, L.; Catt, K. J. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II Mol. Endocrinol. 2006, 20, 953-970
7. 1 receptor entity Nat. Chem. Biol. 2012, 8, 622-630
8. Gether, U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors Endocr. Rev. 2000, 21, 90-113
9. Mavromoustakos, T.; Kolocouris, A.; Zervou, M.; Roumelioti, P.; Matsoukas, J.; Weisemann, R. An effort to understand the molecular basis of hypertension through the study of conformational analysis of losartan and sarmesin using a combination of nuclear magnetic resonance spectroscopy and theoretical calculations J. Med. Chem. 1999, 42, 1714-1722
10. 1 antagonist J. Pharm. Biomed. Anal. 2002, 28, 125-135
11. 1 antagonists: stereoelectronic requirements for antihypertensive efficacy J. Pharm. Biomed. Anal. 2003, 31, 833-844
12. 1 antagonist J. Pharm. Biomed. Anal. 2006, 40, 1097-1104
13. 1 receptor for computational docking studies Drug Des. Rev. 2005, 2, 537-545
14. 1 receptor Chem. Phys. Lipids. 2003, 125, 13-25
15. Matsoukas, M.-T.; Zoumpoulakis, P.; Tselios, T. Conformational analysis of aliskiren, a potent renin inhibitor, using high-resolution nuclear magnetic resonance and molecular dynamics simulations J. Chem. Inf. Model. 2011, 51, 2386-2397
16. Matsoukas, J. M.; Scanlon, M. N.; Moore, G. J. A cyclic angiotensin antagonist: [1,8-cysteine]angiotensin II J. Med. Chem. 1984, 27, 404-406
17. Matsoukas, J. M.; Moore, G. J. NMR studies on angiotensin II: Histidine and phenylalanine ring stacking and biological activity Biochem. Biophys. Res. Commun. 1984, 122, 434-438
18. Matsoukas, J.; Cordopatis, P.; Belte, U.; Goghari, M. H.; Ganter, R. C.; Franklin, K. J.; Moore, G. J. Importance of the N-terminal domain of the type II angiotensin antagonist sarmesin for receptor blockade J. Med. Chem. 1988, 31, 1418-1421
19. Matsoukas, J. M.; Moore, G. J. NMR and mass spectroscopic studies of the competitive-angiotensin II antagonist ″sarmesin″ Spectrosc. Lett. 1988, 21, 477-491
20. 1]angiotensin II on conformation and activity J. Biol. Chem. 1994, 269, 5303-5312
21. Matsoukas, J. M.; Polevaya, L.; Ancans, J.; Mavromoustakos, T.; Kolocouris, A.; Roumelioti, P.; Vlahakos, D. V.; Yamdagni, R.; Wu, Q.; Moore, G. J. The design and synthesis of a potent angiotensin II cyclic analogue confirms the ring cluster receptor conformation of the hormone angiotensin II Bioorg. Med. Chem. 2000, 8, 1-10
22. Matsoukas, J. M.; Goghari, M. H.; Moore, G. J. Proton magnetic resonance studies of angiotensin II conformation: chemical shifts for the aromatic protons of selected analogues in DMSO-d6 at 400 Mz. In Peptides 1986, Walter de Gruyter & Co: Berlin, 1987; pp 335-339.
23. Moore, G. J.; Matsoukas, J. M. Angiotensin as a model for hormone-receptor interactions Biosci. Rep. 1985, 5, 407-416
24. Tzakos, A. G.; Bonvin, A. M. J. J.; Troganis, A.; Cordopatis, P.; Amzel, M. L.; Gerothanassis, I. P.; van Nuland, N. A. J. On the molecular basis of the recognition of angiotensin II (AII) Eur. J. Biochem. 2003, 270, 849-860
25. Taddese, B.; Simpson, L. M.; Wall, I. D.; Blaney, F. E.; Reynolds, C. A. Modeling Active GPCR Conformations. In Methods in Enzymology, Conn, P. M., Ed.; Academic Press: 2013; Vol. 522, pp 21-35.
26. Harrison, C. G protein-coupled receptors: Homology model allows effective virtual screening Nat. Rev. Drug Discov. 2011, 10, 816-816
27. Fredriksson, R.; Lagerstrom, M. C.; Lundin, L.-G.; Schioth, H. B. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints Mol. Pharmacol. 2003, 63, 1256-1272
28. Wu, B.; Chien, E. Y. T.; Mol, C. D.; Fenalti, G.; Liu, W.; Katritch, V.; Abagyan, R.; Brooun, A.; Wells, P.; Bi, F. C.; Hamel, D. J.; Kuhn, P.; Handel, T. M.; Cherezov, V.; Stevens, R. C. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists Science 2010, 330, 1066-1071
29. Takezako, T.; Gogonea, C.; Saad, Y.; Noda, K.; Karnik, S. S. "Network leaning" as a mechanism of insurmountable antagonism of the angiotensin II type 1 receptor by non-peptide antagonists J. Biol. Chem. 2004, 279, 15248-15257
30. 1 receptor by cysteine-scanning mutagenesis J. Biol. Chem. 2010, 285, 2284-2293
31. Yamano, Y.; Ohyama, K.; Kikyo, M.; Sano, T.; Nakagomi, Y.; Inoue, Y.; Nakamura, N.; Morishima, I.; Guo, D.-F.; Hamakubo, T.; Inagami, T. Mutagenesis and the molecular modeling of the rat angiotensin II receptor J. Biol. Chem. 1995, 270, 14024-14030
32. 1 receptor is essential for full agonism J. Biol. Chem. 1995, 270, 12846-12850
33. Arsenault, J.; Cabana, J.; Fillion, D.; Leduc, R.; Guillemette, G.; Lavigne, P.; Escher, E. Temperature dependent photolabeling of the human angiotensin II type 1 receptor reveals insights into its conformational landscape and its activation mechanism Biochem. Pharmacol. 2010, 80, 990-999
34. Ballesteros, J. A.; Weinstein, H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. In Methods in Neurosciences, Stuart, C. S., Ed.; Academic Press: 1995; Vol. 25, pp 366-428.
35. Noda, K.; Saad, Y.; Kinoshita, A.; Boyle, T. P.; Graham, R. M.; Husain, A.; Karnik, S. S. Tetrazole and carboxylate groups of angiotensin receptor antagonists bind to the same subsite by different mechanisms J. Biol. Chem. 1995, 270, 2284-2289
36. Hansson, T.; Marelius, J.; Aqvist, J. Ligand binding affinity prediction by linear interaction energy methods J. Comput-Aided. Mol. Des. 1998, 12, 27-35
37. Martin, S. S.; Holleran, B. J.; Escher, E.; Guillemette, G.; Leduc, R. Activation of the angiotensin II type 1 receptor leads to movement of the sixth transmembrane domain: Analysis by the substituted cysteine accessibility method Mol. Pharmacol. 2007, 72, 182-190
38. 1) receptor bound to angiotensin II from multiple chemoselective photoprobe contacts reveals a unique peptide binding mode J. Biol. Chem. 2013, 288, 8187-8197
39. Eswar, N.; Webb, B.; Marti-Renom, M. A.; Madhusudhan, M. S.; Eramian, D.; Shen, M.-y.; Pieper, U.; Sali, A. Comparative protein structure modeling using Modeller. In Current Protocols in Bioinformatics, John Wiley & Sons, Inc.: 2002.
40. Boucard, A. A. Constitutive activation of the angiotensin II type 1 receptor alters the spatial proximity of transmembrane 7 to the ligand-binding pocket J. Biol. Chem. 2003, 278, 36628-36636
41. Bockenhauer, S.; Furstenberg, A.; Yao, X. J.; Kobilka, B. K.; Moerner, W. E. Conformational dynamics of single G protein-coupled receptors in solution J. Phys. Chem. B 2011, 115, 13328-13338
42. 2-adrenergic receptor activation Cell 2013, 152, 532-542
43. 2 adrenergic G-protein-coupled receptor Nature 2007, 450, 383-388
44. 2-AR and a photoactivated intermediate of rhodopsin identified by dynamic properties of GPCRs Biochemistry 2008, 47, 7317-7321
45. Cabana, J.; Holleran, B.; Beaulieu, M.-E.; Leduc, R.; Escher, E.; Guillemette, G.; Lavigne, P. Critical hydrogen bond formation for activation of the angiotensin II type 1 receptor J. Biol. Chem. 2013, 288, 2593-2604
46. Griesinger, C.; Ernst, R. R. Frequency offset effects and their elimination in NMR rotating-frame cross-relaxation spectroscopy J. Magn. Reson. 1987, 75, 261-271
47. MacroModel, version 9.9; Schrodinger, LLC: New York, NY, 2012.
48. The UniProt Consortium Reorganizing the protein space at the Universal Protein Resource (UniProt) Nucleic Acids Res. 2012, 40, D71-D75
49. Li, J.; Edwards, P.; Burghammer, M.; Villa, C.; Schertler, G. Structure of bovine rhodopsin in a trigonal crystal form J. Mol. Biol. 2004, 343, 1409-1438
50. Shen, M.-Y.; Sali, A. Statistical potential for assessment and prediction of protein structures Protein Sci. 2006, 15, 2507-2524
51. Laskowski, R. A.; MacArthur, M. W.; Moss, D. S.; Thornton, J. M. PROCHECK: a program to check the stereochemical quality of protein structures J. Appl. Crystallogr. 1993, 26, 283-291
52. Glide, Induced Fit Docking protocol, version 5.8; Schrodinger, LLC: New York, NY, 2012.
53. 1 angiotensin receptor Br. J. Pharmacol. 1996, 119, 1505-1507
54. 274 disulfide bond and of the third extracellular loop in the constitutive activation and internalization of angiotensin II type 1 receptor Regul. Pept. 2006, 134, 132-140
55. Ohno, K.; Amano, Y.; Kakuta, H.; Niimi, T.; Takakura, S.; Orita, M.; Miyata, K.; Sakashita, H.; Takeuchi, M.; Komuro, I.; Higaki, J.; Horiuchi, M.; Kim-Mitsuyama, S.; Mori, Y.; Morishita, R.; Yamagishi, S.-i. Unique ″delta lock″ structure of telmisartan is involved in its strongest binding affinity to angiotensin II type 1 receptor Biochem. Biophys. Res. Commun. 2011, 404, 434-437
56. Miura, S.-I.; Fujino, M.; Hanzawa, H.; Kiya, Y.; Imaizumi, S.; Matsuo, Y.; Tomita, S.; Uehara, Y.; Karnik, S. S.; Yanagisawa, H.; Koike, H.; Komuro, I.; Saku, K. Molecular mechanism underlying inverse agonist of angiotensin II type 1 receptor J. Biol. Chem. 2006, 281, 19288-19295
57. Fiser, A.; Do, R. K. G.; Šali, A. Modeling of loops in protein structures Protein Sci. 2000, 9, 1753-1773
58. Berendsen, H. J. C.; van der Spoel, D.; van Drunen, R. GROMACS: A message-passing parallel molecular dynamics implementation Comput. Phys. Commun. 1995, 91, 43-56
59. Cordomí, A.; Edholm, O.; Perez, J. J. Effect of different treatments of long-range interactions and sampling conditions in molecular dynamic simulations of rhodopsin embedded in a dipalmitoyl phosphatidylcholine bilayer J. Comput. Chem. 2007, 28, 1017-1030
60. Lindorff-Larsen, K.; Piana, S.; Palmo, K.; Maragakis, P.; Klepeis, J. L.; Dror, R. O.; Shaw, D. E. Improved side-chain torsion potentials for the Amber ff99SB protein force field Proteins: Struct. Funct. Bioinf. 2010, 78, 1950-1958
61. Berger, O.; Edholm, O.; Jähnig, F. Molecular dynamics simulations of a fluid bilayer of dipalmitoylphosphatidylcholine at full hydration, constant pressure, and constant temperature Biophys. J. 1997, 72, 2002-2013
62. Cordomi, A.; Caltabiano, G.; Pardo, L. Membrane protein simulations using AMBER force field and Berger lipid parameters J. Chem. Theory Comput. 2012, 8, 948-958
63. Miyamoto, S.; Kollman, P. A. Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models J. Comput. Chem. 1992, 13, 952-962
64. Darden, T.; York, D.; Pedersen, L. Particle mesh Ewald: An N log(N) method for Ewald sums in large systems J. Chem. Phys. 1993, 98, 10089-10092
65. Almlöf, M.; Åqvist, J.; SmalaÌŠs, A. O.; Brandsdal, B. O. Probing the effect of point mutations at protein-protein interfaces with free energy calculations Biophys. J. 2006, 90, 433-442